Carrier strategies boost the application of CRISPR/Cas system in gene therapy

Abstract

Emerging clustered regularly interspaced short palindromic repeat/associated protein (CRISPR/Cas) genome editing technology shows great potential in gene therapy. However, proteins and nucleic acids suffer from enzymatic degradation in the physiological environment and low permeability into cells. Exploiting carriers to protect the CRISPR system from degradation, enhance its targeting of specific tissues and cells, and reduce its immunogenicity is essential to stimulate its clinical applications. Here, the authors review the state-of-the-art CRISPR delivery systems and their applications, and describe strategies to improve the safety and efficacy of CRISPR mediated genome editing, categorized by three types of cargo formats, that is, Cas: single-guide RNA ribonucleoprotein, Cas mRNA and single-guide RNA, and Cas plasmid expressing CRISPR/Cas systems. The authors hope this review will help develop safe and efficient nanomaterial-based carriers for CRISPR tools.

Macrophage-Membrane-Camouflaged Nonviral Gene Vectors for the Treatment of Multidrug-Resistant Bacterial Sepsis

“…Gene therapy offers a solution to these issues. Plasmid DNA ( p DNA) can be expressed transiently or for a long time using a vector-mediated gene delivery system. − Metal–organic frameworks (MOFs) have been successfully used for the delivery of biomolecules such as protein and nucleic acids because of their low toxicity and pH-responsive properties. − Among them, zeolite imidazolate framework (ZIF-8) has been used for p DNA delivery based on the synergistic effect of Zn 2+ to promote p DNA nuclear translocation to enhance gene transfection activity. , However, most of these nanoparticles are recognized and cleared from the phagocytic system before they reach the target tissue . More importantly, they cannot easily pass complex biological barriers and do not have chemotactic features, resulting in inefficient delivery to the targeted tissue …”

BACE1 Aptamer-Modified Tetrahedral Framework Nucleic Acid to Treat Alzheimer’s Disease in an APP-PS1 Animal Model

“…With the development of nanotechnology, various nanoparticle delivery systems have been used to assist drugs in crossing the BBB to enter the brain. Such systems include protein-mimicking nanoparticles, liposomes, solid-lipid nanoparticles, polymeric nanoparticles, and inorganic nanoparticles, among others. − Nevertheless, nanoparticle carriers also have side effects, which limit their clinical application.…”

Recent advances in biological detection with rolling circle amplification: design strategy, biosensing mechanism, and practical applications

“…For the past few years, people have experienced the mushrooming growth of medical diagnostic technology with the dis-covery of protein biomarkers (such as specific antigens and surface proteins from cancer cells) and nucleic acid biomarkers (such as circulating tumor-derived DNA and microRNA). [1][2][3] The high sensitivity detection of various biomarkers has played a positive role in the early diagnosis of diseases and feedback in clinical treatment results. [4][5][6] Therefore, achieving highly sensitive detection is an important goal in the development of novel biosensing methodologies for disease-related biomarkers.…”